Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Extends License for Linguamatics Software

NEW YORK (GenomeWeb News) – Linguamatics said today that AstraZeneca has extended its license for the company's I2E text-mining platform in a multi-year deal.

AstraZeneca has been a Linguamatics customer since 2003.

Financial terms of the agreement were not disclosed.

Ian Dix, who heads AstraZeneca's knowledge engineering capability team, said in a statement that the company is using I2E "for knowledge discovery to support better-informed scientific decision-making, impacting discovery performance and competitiveness." In particular, he said that the software is useful for early prediction of candidate drug efficacy and safety.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.